Stacie Weninger
Harvard University
Tell me more about Stacie Weninger?
Stacie Weninger is the President of FBRI, a venture capital firm based in Boston, Massachusetts. Prior to this role, she held various positions at Harvard University, including Senior Director of Science Programs and Senior Scientist at Cell Press. She also has experience as a postdoctoral researcher at Children's Hospital Boston and Harvard Medical School. Stacie Weninger has a Ph.D. in neuroscience from Harvard University and a B.S. degree in chemistry with highest honors from the University of North Carolina. She is currently the President of Alzforum, the Chairman of the Board of Directors for Rugen Therapeutics, and the Board of Directors for Denali Therapeutics and Annexon Biosciences.
For inquiries about Phone Number and Email, please click here Unlock Contact
Emails and Phone Numbers
About
Stacie Weninger is the President of FBRI. Prior to this position, she was the Senior Director of Science Programs for the Fidelity Foundations. In 2005, Dr. Weninger served as the Project Manager and Senior Analyst for the Task Force on Women in Science at Harvard University. From 2001-2005, Dr. Weninger was a Senior Scientist at Cell Press for the journal Neuron. Before joining Cell Press, Dr. Weninger was a postdoctoral research fellow at Children’s Hospital Boston and Harvard Medical School with Dr. Bruce Yankner. She was a Howard Hughes Medical Institute predoctoral fellow in the Program in Neuroscience at Harvard University. While a graduate student and postdoctoral research fellow, Dr. Weninger was actively involved in undergraduate teaching, winning six teaching awards. Dr. Weninger received a Ph.D. in neuroscience from Harvard University, and a B.S. degree in chemistry with highest honors from the University of North Carolina, Chapel Hill. She currently chairs the Collaboration for Alzheimer’s Prevention; is President of Alzforum; serves as Chairman of the Board of Directors for Rugen Therapeutics; serves as a member of the Board of Directors for Enspectra, Aratome, Q-State Biosciences, Digital Cognition Technologies, and Target ALS; and she previously served as a founding member of the Board of Directors for Denali Therapeutics (NASDAQ: DNLI) as well as a member of the Board of Directors for Annexon Biosciences, BRI-Alzan (acquired by MeiraGTx), and Inscopix.
...See MoreWork Experience
President
Venture Capital and Private Equity Principals
Stacie Weninger's Professional Milestones
- President: Transformed the company's performance through strategic initiatives through effective leadership and collaboration with key stakeholders.
Education
Neuroscience,
Ph.d.
Skill
Venture Capital
Certification
Colleagues
Davina Magargal
vp of marketing at f-prime capital
Rachel Woolbert
senior executive assistant to president and managing partner
Rachel Feely-Kohl
vp community & platform at f-prime capital
Mary Bevelock
Chief Operating Officer
Shervin Ghaemmaghami
Senior Vice President
Other Named Stacie Weninger
Frequently asked questions
We found 2 Stacie Weninger's email addresses
We found 1 Stacie Weninger's phone numbers
Stacie Weninger's social media include: Linkedin,
Stacie Weninger works for F-Prime Capital
Stacie Weninger's role in F-Prime Capital is President
Stacie Weninger works in the industry of Venture Capital and Private Equity Principals
Stacie Weninger's colleagues are Davina Magargal,Rachel Woolbert,Rachel Feely-Kohl
Stacie Weninger's latest job experience is President at F-Prime Capital
Stacie Weninger's latest education in Harvard University